NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . April 13th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

Cancer Vaccines - New cancer vaccines study results from Uppsala University described

HIV/AIDS - New findings from University of Mannheim in the area of HIV/AIDS described

HIV/AIDS - Reports outline HIV/AIDS study results from Indiana University

HIV/AIDS - Scientists at National Institutes of Health report research in HIV/AIDS

HIV/AIDS - Studies from Yale University, Medical Department in the area of HIV/AIDS described

HIV/AIDS - Education Slowing AIDS in Sub-Saharan Africa

HIV/AIDS - Immunotech Completes Merger Acquisition

Influenza - Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray

Theraclone Sciences, Inc. - Spaltudaq Corp. Announces Identification of Broadly and Potently Neutralizing Human HIV Antibodies and Change of Company Name to Theraclone Sciences, Inc.



Return to Top of Page

-----------------------
PR Login